iNOS expression in vascular resident macrophages contributes to circulatory dysfunction of splanchnic vascular smooth muscle contractions in portal hypertensive rats

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 300, Issue 3, 2011, Pages

  Kajita, Masahiro ^a   Murata, Takahisa ^a   Horiguchi, Kazuhide ^b   Iizuka, Masateru ^a   Hori, Masatoshi ^a   Ozaki, Hiroshi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF FUKUI   (Japan)

Author keywords

Cirrhosis; Inflammation; Nitric oxide sensitivity; Vasodialation

Indexed keywords

8 BROMO CYCLIC GMP; CYCLIC GMP; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; MYOSIN LIGHT CHAIN; NITRATE; NITRITE; NITROPRUSSIDE SODIUM;

ALPHA ADRENERGIC STIMULATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT; BLOOD VESSEL WALL; CALCIUM CELL LEVEL; CONTROLLED STUDY; CYTOSOL; IMMUNOHISTOCHEMISTRY; ISCHEMIA; MACROPHAGE; MALE; MESENTERIC ARTERY; MONOCYTE; NONHUMAN; ORGAN CULTURE; PORTAL HYPERTENSION; PORTAL VEIN; PORTAL VEIN BLOOD FLOW; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SMOOTH MUSCLE CONTRACTION; VASCULAR SMOOTH MUSCLE; VEIN BLOOD FLOW;

ANIMALS; CALCIUM; CYCLIC GMP; HYPERTENSION, PORTAL; LIPOPOLYSACCHARIDES; LIVER CIRRHOSIS; MACROPHAGES; MALE; MESENTERIC ARTERIES; MONOCYTES; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; MYOSIN LIGHT CHAINS; NG-NITROARGININE METHYL ESTER; NITRATES; NITRIC OXIDE SYNTHASE TYPE II; NITROPRUSSIDE; PORTAL VEIN; RATS; RATS, SPRAGUE-DAWLEY; SPLANCHNIC CIRCULATION; VASODILATOR AGENTS;

EID: 79955074965     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00563.2009     Document Type: Article

References (50)

1. Akiho H, Blennerhassett P, Deng Y, Collins SM. Role of IL-4, IL-13, and STAT6 in inflammation-induced hypercontractility of murine smooth muscle cells. Am J Physiol Gastrointest Liver Physiol 282: G226-G232, 2002.
2. Albillos A, de la Hera A, Gonzalez M, Moya JL, Calleja JL, Monserrat J, Ruiz-del-Arbol L, Alvarez-Mon M. Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement. Hepatology 37: 208-217, 2003.
3. Bhimani EK, Serracino-Inglott F, Sarela AI, Batten JJ, Mathie RT. Hepatic and mesenteric nitric oxide synthase expression in a rat model of CCl(4)-induced cirrhosis. J Surg Res 113: 172-178, 2003.
4. Bosch J, Berzigotti A, Garcia-Pagan JC, Abraldes JG. The management of portal hypertension: rational basis, available treatments and future options. J Hepatol 48, Suppl 1: S68-S92, 2008.
5. Boyle JJ. Macrophage activation in atherosclerosis: pathogenesis and pharmacology of plaque rupture. Curr Vasc Pharmacol 3: 63-68, 2005.
6. Chiva M, Guarner C, Peralta C, Llovet T, Gomez G, Soriano G, Balanzo J. Intestinal mucosal oxidative damage and bacterial translocation in cirrhotic rats. Eur J Gastroenterol Hepatol 15: 145-150, 2003.
7. Clements WD, Erwin P, McCaigue MD, Halliday I, Barclay GR, Rowlands BJ. Conclusive evidence of endotoxaemia in biliary obstruction. Gut 42: 293-299, 1998.
8. Collett GD, Canfield AE. Angiogenesis and pericytes in the initiation of ectopic calcification. Circ Res 96: 930-938, 2005.
9. Ferguson JW, Dover AR, Chia S, Cruden NL, Hayes PC, Newby DE. Inducible nitric oxide synthase activity contributes to the regulation of peripheral vascular tone in patients with cirrhosis and ascites. Gut 55: 542-546, 2006.
10. Friebe A, Koesling D. Regulation of nitric oxide-sensitive guanylyl cyclase. Circ Res 93: 96-105, 2003.
11. Griendling KK, FitzGerald GA. Oxidative stress and cardiovascular injury: Part II: animal and human studies. Circulation 108: 2034-2040, 2003.
12. Han JW, Shimada K, Ma-Krupa W, Johnson TL, Nerem RM, Goronzy JJ, Weyand CM. Vessel wall-embedded dendritic cells induce T-cell autoreactivity and initiate vascular inflammation. Circ Res 102: 546-553, 2008.
13. Hori M, Kita M, Torihashi S, Miyamoto S, Won KJ, Sato K, Ozaki H, Karaki H. Upregulation of iNOS by COX-2 in muscularis resident macrophage of rat intestine stimulated with LPS. Am J Physiol Gastrointest Liver Physiol 280: G930-G938, 2001.
14. Hori M, Nobe H, Horiguchi K, Ozaki H. MCP-1 targeting inhibits muscularis macrophage recruitment and intestinal smooth muscle dysfunction in colonic inflammation. Am J Physiol Cell Physiol 294: C391-C401, 2008.
15. Iwakiri Y, Groszmann RJ. The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule. Hepatology 43: S121-S131, 2006.
16. Karaki H, Ozaki H, Hori M, Mitsui-Saito M, Amano K, Harada K, Miyamoto S, Nakazawa H, Won KJ, Sato K. Calcium movements, distribution, and functions in smooth muscle. Pharmacol Rev 49: 157-230, 1997.
17. Kinoshita K, Hori M, Fujisawa M, Sato K, Ohama T, Momotani E, Ozaki H. Role of TNF-alpha in muscularis inflammation and motility disorder in a TNBS-induced colitis model: clues from TNF-alpha-deficient mice. Neurogastroenterol Motil 18: 578-588, 2006.
18. Kinoshita K, Horiguchi K, Fujisawa M, Kobirumaki F, Yamato S, Hori M, Ozaki H. Possible involvement of muscularis resident macrophages in impairment of interstitial cells of Cajal and myenteric nerve systems in rat models of TNBS-induced colitis. Histochem Cell Biol 127: 41-53, 2007.
19. Kleschyov AL, Muller B, Keravis T, Stoeckel ME, Stoclet JC. Adventitia-derived nitric oxide in rat aortas exposed to endotoxin: cell origin and functional consequences. Am J Physiol Heart Circ Physiol 279: H2743-H2751, 2000.
20. Kleschyov AL, Muller B, Schott C, Stoclet JC. Role of adventitial nitric oxide in vascular hyporeactivity induced by lipopolysaccharide in rat aorta. Br J Pharmacol 124: 623-626, 1998.
21. Lumsden AB, Henderson JM, Kutner MH. Endotoxin levels measured by a chromogenic assay in portal, hepatic and peripheral venous blood in patients with cirrhosis. Hepatology 8: 232-236, 1988.
22. MacMicking J, Xie QW, Nathan C. Nitric oxide and macrophage function. Annu Rev Immunol 15: 323-350, 1997.
23. Maiellaro K, Taylor WR. The role of the adventitia in vascular inflammation. Cardiovasc Res 75: 640-648, 2007.
24. Malyshev E, Tazi KA, Moreau R, Lebrec D. Discrepant effects of inducible nitric oxide synthase modulation on systemic and splanchnic endothelial nitric oxide synthase activity and expression in cirrhotic rats. J Gastroenterol Hepatol 22: 2195-2201, 2007.
25. McLemore EC, Tessier DJ, Thresher J, Komalavilas P, Brophy CM. Role of the small heat shock proteins in regulating vascular smooth muscle tone. J Am Coll Surg 201: 30-36, 2005.
26. Merx MW, Weber C. Sepsis and the heart. Circulation 116: 793-802, 2007.
27. Moreau R, Barriere E, Tazi KA, Lardeux B, Dargere D, Urbanowicz W, Poirel O, Chauvelot-Moachon L, Guimont MC, Bernuau D, Lebrec D. Terlipressin inhibits in vivo aortic iNOS expression induced by lipopolysaccharide in rats with biliary cirrhosis. Hepatology 36: 1070-1078, 2002.
28. Murthy KS. Signaling for contraction and relaxation in smooth muscle of the gut. Annu Rev Physiol 68: 345-374, 2006.
29. Ohama T, Hori M, Sato K, Ozaki H, Karaki H. Chronic treatment with interleukin-1beta attenuates contractions by decreasing the activities of CPI-17 and MYPT-1 in intestinal smooth muscle. J Biol Chem 278: 48794-48804, 2003.
30. Ozaki H, Kawai T, Shuttleworth CW, Won KJ, Suzuki T, Sato K, Horiguchi H, Hori M, Karaki H, Torihashi S, Ward SM, Sanders KM. Isolation and characterization of resident macrophages from the smooth muscle layers of murine small intestine. Neurogastroenterol Motil 16: 39-51, 2004.
31. Ozaki H, Sato K, Satoh T, Karaki H. Simultaneous recordings of calcium signals and mechanical activity using fluorescent dye fura 2 in isolated strips of vascular smooth muscle. Jpn J Pharmacol 45: 429-433, 1987.
32. Pizcueta MP, Pique JM, Bosch J, Whittle BJ, Moncada S. Effects of inhibiting nitric oxide biosynthesis on the systemic and splanchnic circulation of rats with portal hypertension. Br J Pharmacol 105: 184-190, 1992.
33. Prabhu SD. Cytokine-induced modulation of cardiac function. Circ Res 95: 1140-1153, 2004.
34. Rembold CM, Foster DB, Strauss JD, Wingard CJ, Eyk JE. cGMPmediated phosphorylation of heat shock protein 20 may cause smooth muscle relaxation without myosin light chain dephosphorylation in swine carotid artery. J Physiol 524: 865-878, 2000.
35. Rembold CM, O'Connor M, Clarkson M, Wardle RL, Murphy RA. Selected contribution: HSP20 phosphorylation in nitroglycerin-and forskolin-induced sustained reductions in swine carotid media tone. J Appl Physiol 91: 1460-1466, 2001.
36. +-induced contraction by the ROCKs inhibitor Y-27632 in vascular smooth muscle: possible involvement of ROCKs in a signal transduction pathway. J Pharm Sci 92: 56-69, 2003.
37. Sanyal AJ, Bosch J, Blei A, Arroyo V. Portal hypertension and its complications. Gastroenterology 134: 1715-1728, 2008.
38. Schuppan D, Afdhal NH. Liver cirrhosis. Lancet 371: 838-851, 2008.
39. Schwarz NT, Kalff JC, Turler A, Engel BM, Watkins SC, Billiar TR, Bauer AJ. Prostanoid production via COX-2 as a causative mechanism of rodent postoperative ileus. Gastroenterology 121: 1354-1371, 2001.
40. Seki E, Brenner DA. Toll-like receptors and adaptor molecules in liver disease: update. Hepatology 48: 322-335, 2008.
41. 2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev 83: 1325-1358, 2003.
42. Theodorakis NG, Wang YN, Skill NJ, Metz MA, Cahill PA, Redmond EM, Sitzmann JV. The role of nitric oxide synthase isoforms in extrahepatic portal hypertension: studies in gene-knockout mice. Gastroenterology 124: 1500-1508, 2003.
43. Vallance BA, Radojevic N, Hogaboam CM, Deng Y, Gauldie J, Collins SM. IL-4 gene transfer to the small bowel serosa leads to intestinal inflammation and smooth muscle hyperresponsiveness. Am J Physiol Gastrointest Liver Physiol 292: G385-G394, 2007.
44. Van Kampen C, Gauldie J, Collins SM. Proinflammatory properties of IL-4 in the intestinal microenvironment. Am J Physiol Gastrointest Liver Physiol 288: G111-G117, 2005.
45. von der Leyen HE, Dzau VJ. Therapeutic potential of nitric oxide synthase gene manipulation. Circulation 103: 2760-2765, 2001.
46. Wei CL, Hon WM, Lee KH, Khoo HE. Chronic administration of aminoguanidine reduces vascular nitric oxide production and attenuates liver damage in bile duct-ligated rats. Liver Int 25: 647-656, 2005.
47. Wilcox JN, Okamoto EI, Nakahara KI, Vinten-Johansen J. Perivascular responses after angioplasty which may contribute to postangioplasty restenosis: a role for circulating myofibroblast precursors? Ann NY Acad Sci 947: 68-90, 2001.
48. Yamashita A, Shoji K, Tsuruda T, Furukoji E, Takahashi M, Nishihira K, Tamura S, Asada Y. Medial and adventitial macrophages are associated with expansive atherosclerotic remodeling in rabbit femoral artery. Histol Histopathol 23: 127-136, 2008.
49. Yamawaki H, Sato K, Hori M, Ozaki H, Nakamura S, Nakayama H, Doi K, Karaki H. Impairment of EDR by a long-term PDGF treatment in organ-cultured rabbit mesenteric artery. Am J Physiol Heart Circ Physiol 277: H318-H323, 1999.
50. Zhang H, Du Y, Cohen RA, Chobanian AV, Brecher P. Adventitia as a source of inducible nitric oxide synthase in the rat aorta. Am J Hypertens 12: 467-475, 1999.